Rocket Pharmaceuticals: 2Q Earnings Snapshot
NEW YORK (AP) _ Rocket Pharmaceuticals Inc. (RCKT) on Wednesday reported a loss of $18.7 million in its second quarter.
On a per-share basis, the New York-based company said it had a loss of 38 cents.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 49 cents per share.
Rocket Pharmaceuticals shares have declined 22% since the beginning of the year. The stock has fallen 44% in the last 12 months.